{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:06:58Z","timestamp":1789132018491,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","annemergmed.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.annemergmed.2017.04.034","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T04:46:41Z","timestamp":1497415601000},"page":"233-244.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue\u00a0Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial"],"prefix":"10.1016","volume":"70","author":[{"given":"Charles J.","family":"Gerardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Rutherfoord","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Toschlog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gasior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lavonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2017.04.034_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1580\/06-WEME-OR-080R1.1","article-title":"Snakebite injuries treated in United States emergency departments, 2001-2004","volume":"18","author":"O\u2019Neil","year":"2007","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/15563650.2015.1102927","article-title":"2014 Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 32nd annual report","volume":"53","author":"Mowry","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annemergmed.2014.08.006","article-title":"Lack of coagulopathy after copperhead snakebites","volume":"65","author":"Ali","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib4","first-page":"1","article-title":"FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction?","volume":"22","author":"Gale","year":"2016","journal-title":"J\u00a0Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jamcollsurg.2010.12.049","article-title":"Current management of copperhead snakebite","volume":"212","author":"Walker","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib6","first-page":"29","article-title":"Copperhead envenomations in the Carolinas","volume":"41","author":"Thorson","year":"2003","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.annemergmed.2003.08.009","article-title":"Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite","volume":"43","author":"Lavonas","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1553-2712.2010.00958.x","article-title":"Factors associated with difficulty achieving initial control with Crotalidae polyvalent immune fab antivenom in snakebite patients","volume":"18","author":"Yin","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15563650.2016.1250275","article-title":"Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab\u2032)2 versus Fab antivenom trial","volume":"55","author":"Gerardo","year":"2017","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib10","first-page":"125","article-title":"Prospective study of morbidity associated with snakebite envenomation","volume":"41","author":"Spiller","year":"2003","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0196-0644(97)70107-0","article-title":"Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning","volume":"30","author":"Dart","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib12","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/archinte.161.16.2030","article-title":"A\u00a0randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment of crotaline snakebite in the United States","volume":"161","author":"Dart","year":"2001","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/1740774514543538","article-title":"Ethical considerations in design of a study to evaluate a US Food and Drug Administration\u2013approved indication: antivenom versus placebo for copperhead envenomation","volume":"11","author":"Gerardo","year":"2014","journal-title":"J\u00a0Clin Trials"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1553-2712.2011.01276.x","article-title":"Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis","volume":"19","author":"Schaeffer","year":"2012","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMra013477","article-title":"Bites of venomous snakes","volume":"347","author":"Gold","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-227X-11-2","article-title":"Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop","volume":"11","author":"Lavonas","year":"2011","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.wem.2015.05.007","article-title":"Wilderness Medical Society practice guidelines for the treatment of pitviper envenomations in the United States and Canada","volume":"26","author":"Kanaan","year":"2015","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.amjsurg.2006.08.056","article-title":"A\u00a0large single-center experience with treatment of patients with crotalid envenomations: outcomes with and evolution of antivenin therapy","volume":"192","author":"Corneille","year":"2006","journal-title":"Am J Surg"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/acem.12598","article-title":"Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population","volume":"22","author":"Gerardo","year":"2015","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib20","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.annemergmed.2014.07.424","article-title":"Variability in antivenom treatment in snake envenomations between two major tertiary care emergency departments","volume":"64","author":"Ward","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mem.2001.116148","article-title":"Copperhead snakebites: clinical severity of local effects","volume":"38","author":"Scharman","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12873-015-0033-6","article-title":"Prospective study of recovery from copperhead snake envenomation: an observational study","volume":"15","author":"Lavonas","year":"2015","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/15563650.2015.1130227","article-title":"Prospective evaluation of pain, swelling, and disability from copperhead envenomation","volume":"54","author":"Roth","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.annemergmed.2003.11.013","article-title":"Copperhead bites and Crotalidae polyvalent immune Fab (ovine): routine use requires evidence of improved outcomes","volume":"43","author":"Caravati","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3138\/ptc.47.4.258","article-title":"Assessing disability and change on individual patients: a report of a patient specific measure","volume":"47","author":"Stratford","year":"1995","journal-title":"Physiother Can"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib26","first-page":"649","article-title":"Validation of Patient Specific Functional Scale in copperhead snakebite patients","volume":"53","author":"Anderson","year":"2015","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2519\/jospt.2012.3953","article-title":"The Patient-Specific Functional Scale: validity, reliability, and responsiveness in patients with upper extremity musculoskeletal problems","volume":"42","author":"Hefford","year":"2012","journal-title":"J\u00a0Orthop Sports Phys Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0894-1130(01)80043-0","article-title":"Measuring the whole or the parts? validity, reliability, and responsiveness of the disabilities of the\u00a0arm, shoulder and hand outcome measure in different regions of the upper extremity","volume":"14","author":"Beaton","year":"2001","journal-title":"J\u00a0Hand Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib29","first-page":"371","article-title":"The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application","volume":"79","author":"Binkley","year":"1999","journal-title":"Phys Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ptj\/77.8.820","article-title":"The Patient-Specific Functional Scale: measurement properties in patients with knee dysfunction","volume":"77","author":"Chatman","year":"1997","journal-title":"Phys Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2519\/jospt.1998.27.5.331","article-title":"The Patient-Specific Functional Scale: validation of its use in persons with neck dysfunction","volume":"27","author":"Westaway","year":"1998","journal-title":"J\u00a0Orthop Sports Phys Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jclinepi.2013.11.002","article-title":"The Patient-Specific Functional Scale was valid for the group level change comparisons and between group discrimination","volume":"67","author":"Abbot","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1179\/2042618612Y.0000000006","article-title":"The use of the Patient-Specific Functional Scale to measure rehabilitative progress in a physiotherapy setting","volume":"20","author":"Nicholas","year":"2012","journal-title":"J\u00a0Manual Manipulative Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib34","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s00586-015-4236-z","article-title":"Reliability, validity, and responsiveness of the Japanese version of the Patient-Specific Functional Scale in patients with neck pain","volume":"24","author":"Namamaru","year":"2015","journal-title":"Eur Spine J"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2519\/jospt.2014.5133","article-title":"Evaluative measurements properties of the Patient-Specific Functional Scale for the primary shoulder complaints in physical therapy practice","volume":"44","author":"Koehorst","year":"2014","journal-title":"J\u00a0Orthop Sports Phys Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3461","article-title":"Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory","volume":"13","author":"Fries","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0266462399154102","article-title":"Comparison of an ordinal and a continuous outcome measure of muscle soreness","volume":"15","author":"Vickers","year":"1999","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmpt.2003.11.003","article-title":"Assessing the clinical significance of change scores recorded on subjective outcome measures","volume":"27","author":"Hurst","year":"2004","journal-title":"J\u00a0Manipulative Physiol Ther"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1529-8027.2011.00318.x","article-title":"Revised normative values for grip strength with the Jamar dynamometer","volume":"16","author":"Peters","year":"2011","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ageing\/26.1.15","article-title":"Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants","volume":"26","author":"Bohannon","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib41","unstructured":"US Department of Health and Human Services. FDA Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA\/BE Studies. 2010. Available at: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM332846.pdf. Accessed May 22, 2017."},{"key":"10.1016\/j.annemergmed.2017.04.034_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1994.tb05705.x","article-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH)","volume":"37","author":"Baber","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib43","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.294.17.2203","article-title":"Randomized trials stopped early for benefit: a systematic review","volume":"294","author":"Montori","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.2010.310","article-title":"Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis","volume":"303","author":"Bassler","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib45","first-page":"149","article-title":"Copperhead envenomations: clinical profiles\u00a0of\u00a0three different subspecies","volume":"41","author":"Keyler","year":"1999","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib46","unstructured":"BTG International Inc. CroFab approved package labeling. 2016. Available at: https:\/\/www.crofab.com\/CroFab\/media\/CroFab\/PDF%20Files\/CroFab-Full-Prescribing-Information-2016.pdf. Accessed July 29,\u00a02016."},{"key":"10.1016\/j.annemergmed.2017.04.034_bib47","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.annemergmed.2008.06.354","article-title":"Long-term limb function outcomes following copperhead snakebite","volume":"52","author":"Lavonas","year":"2008","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1875-9114.2012.01026.x","article-title":"Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center","volume":"32","author":"Weant","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/JTN.0000000000000207","article-title":"Management of tissue loss after Agkistrodon snakebite: appropriate use of Crotalidae-Fab antivenin","volume":"23","author":"Larson","year":"2016","journal-title":"J\u00a0Trauma Nurs"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib50","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2105\/AJPH.2014.302147","article-title":"Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic","volume":"104","author":"Beauchamp","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib51","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajem.2016.10.043","article-title":"Something for pain: responsible opioid use in emergency medicine","volume":"35","author":"Strayer","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.annemergmed.2015.11.033","article-title":"Emergency department prescription opioids as an initial exposure preceding addiction","volume":"68","author":"Butler","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2017.04.034_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064417305103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064417305103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T21:58:40Z","timestamp":1569448720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064417305103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0196064417305103"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2017.04.034","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue\u00a0Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2017.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American College of Emergency Physicians. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}